Table 2 –
Incidence and cumulative risk of kidney cancer in America
| Population | Qualitya | Numbers | Crude rate | ASR (W) | Cumulative risk |
|---|---|---|---|---|---|
| USA | A1 | 58 222 | 18.4 | 12.0 | 1.39 |
| Uruguay | A2 | 465 | 13.7 | 9.4 | 1.12 |
| Canada | A1 | 5579 | 16.1 | 9.3 | 1.06 |
| Argentina | B3 | 4068 | 9.9 | 8.0 | 0.93 |
| Chile | C2 | 1353 | 7.8 | 6.0 | 0.72 |
| Puerto Rico | A2 | 272 | 7.3 | 4.9 | 0.56 |
| Costa Rica | A2 | 179 | 3.7 | 3.7 | 0.42 |
| Peru | E3 | 953 | 3.2 | 3.6 | 0.42 |
| Mexico | E1 | 3851 | 3.3 | 3.5 | 0.40 |
| Bolivia | G6 | 263 | 2.6 | 3.5 | 0.41 |
| Belize | G2 | 8 | 2.5 | 3.2 | 0.27 |
| Cuba | C1 | 517 | 4.6 | 3.1 | 0.34 |
| Brazil | B2 | 6255 | 3.2 | 3.0 | 0.33 |
| Ecuador | C3 | 403 | 2.7 | 2.9 | 0.31 |
| Venezuela | G1 | 747 | 2.5 | 2.7 | 0.30 |
| Colombia | C2 | 1048 | 2.2 | 2.4 | 0.26 |
| Trinidad and Tobago | D2 | 32 | 2.4 | 2.3 | 0.23 |
| Guyana | G2 | 14 | 1.8 | 2.2 | 0.21 |
| France, Guadeloupe | G2 | 14 | 3.0 | 2.1 | 0.31 |
| Panama | G2 | 68 | 1.9 | 2.0 | 0.26 |
| Barbados | G2 | 8 | 2.9 | 1.9 | 0.20 |
| Bahamas | G1 | 7 | 2.0 | 1.8 | 0.24 |
| Suriname | G3 | 9 | 1.7 | 1.6 | 0.19 |
| El Salvador | G2 | 93 | 1.5 | 1.5 | 0.17 |
| Nicaragua | G3 | 63 | 1.1 | 1.5 | 0.16 |
| Guatemala | G2 | 150 | 1.0 | 1.5 | 0.17 |
| Honduras | G6 | 80 | 1.0 | 1.5 | 0.16 |
| Paraguay | G3 | 78 | 1.2 | 1.5 | 0.16 |
| France, Martinique | A2 | 11 | 2.7 | 1.4 | 0.15 |
| Jamaica | C3 | 31 | 1.1 | 1.1 | 0.10 |
| French Guiana | G2 | 2 | 0.8 | 0.7 | 0.06 |
| Haiti | G3 | 58 | 0.6 | 0.7 | 0.08 |
| Dominican Republic | G3 | 52 | 0.5 | 0.6 | 0.06 |
ASR = age-standardised rate.
Data are sorted by ASRs. Numbers are expressed per 100 000 people. Reproduced with permission from the International Agency for Research on Cancer [3].
For Quality legend, please refer to the Supplementary material (Level of availability of incidence and mortality data).